Figure 6.Effects of abnormal expression of coagulation-related genes on tumor immune microenvironment. (A) Estimate socre analysis based on coagulation-related risk signature. (B–F) Lymphocyte infiltration analysis based on coagulation-related risk signature. (G–K) Correlation analysis between coagulation-related risk score and immune checkpoint markers. (L–O) IPS score analysis based on coagulation-related risk signature.
